Effects of Telbivudine Treatment on the Circulating CD4⁺ T-Cell Subpopulations in Chronic Hepatitis B Patients

Table 1

Clinical characteristics of the CHB patients at study enrollment.

Patient characteristics at baseline, 𝑛=38
Sex, male (%)	24 (63)
Age, years^a	28 (21–50)
HBV DNA, copies/mL^a	4.6 × 10^8 (1.4 × 10^7–4.2 × 10^9)
ALT^b, units/L^a	134.5 (53–549)
HBsAg^a	13683 (2056–138933)
HBeAg-positive, 𝑛 (%)	38 (100)

ALT: alanine aminotransferase; HBsAg: hepatitis B surface antigen.
^aMedian (range); ^bnormal value: ≤40 IU/L.